Administrative Core

$52,980P01FY2012DKNIH

University Of California, San Diego, La Jolla CA

Investigators

Linked publications, trials & patents

Paper 33649162 Paper 31708444 Paper 31528845 Paper 31010956 Paper 30595478 Paper 30206152 Paper 29779944 Paper 29504946 Paper 29499132 Paper 29328913 Paper 28752547 Paper 28192375 Paper 28041958 Paper 27841948 Paper 27814941 Paper 27814523 Paper 27462873 Paper 27376549 Paper 26822831 Paper 26748707 Paper 26681459 Paper 26582787 Paper 26448649 Paper 26298065 Paper 26166704 Paper 26023106 Paper 25973386 Paper 25846707 Paper 25745059 Paper 25706874 Paper 25619691 Paper 25605944 Paper 25598080 Paper 25480297 Paper 25440058 Paper 25315009 Paper 25244011 Paper 25220417 Paper 25119036 Paper 25074909 Paper 25043058 Paper 25035952 Paper 24997608 Paper 24953653 Paper 24906151 Paper 24419370 Paper 24360279 Paper 24130129 Paper 24121437 Paper 24074869 Paper 24051374 Paper 24030101 Paper 23986717 Paper 23981351 Paper 23959186 Paper 23932714 Paper 23728303 Paper 23705899 Paper 23624976 Paper 23582329 Paper 23525221 Paper 23457303 Paper 23434931 Paper 23415219 Paper 23307734 Paper 23021221 Paper 22921934 Paper 22863787 Paper 22778393 Paper 22653059 Paper 22560216 Paper 22529965 Paper 22493495 Paper 22460790 Paper 22424771 Paper 22344273 Paper 22190646 Paper 22184721 Paper 22078880 Paper 22078878 Paper 21985785 Paper 21980340 Paper 21939287 Paper 21911747 Paper 21903424 Paper 21841783 Paper 21679764 Paper 21572438 Paper 21532596 Paper 21331046 Paper 21307941 Paper 21303545 Paper 21076077 Paper 21045807 Paper 20959535 Paper 20813258 Paper 20651140 Paper 20631355 Patent 9764001 Patent 8987332

Abstract

Core B - Administrative Core: Organizational and Administrative Structure of the Program Project: Dr. Glass will be primarily responsible for decision-making and administration. Dr. Glass holds a primary appointment in the Department of Cellular and Molecular Medicine, Chaired by Dr. Donald Cleveland and a secondary appointment in the Department of Medicine, Chaired by Dr. Wulf Dillman. Dr. Olefsky and Dr. Rosenfeid will constitute an intemal Operating Committee to advise Dr. Glass on organizational and administrative Issues. As each Project and Core will be represented by this committee, the Operating Committee will also represent the chain of responsibility for execution of decisions. An external advisory group will be constituted to review the scientific program on an annual basis. The advisory group will be constituted to include expertise in insulin resistance, nuclear receptor action, inflammation and bioinformatics. The annual review will be performed in the context of a retreat in which all of the significant participants in this PPG will make detailed presentations describing progress and future directions.

View original record on NIH RePORTER →